Breast Reconstruction Autologous with Implant in Rio de Janeiro Brazil
Breast Reconstruction Autologous with Implant in Rio de Janeiro section, includes general infrmation about Breast Reconstruction Autologous with Implant Procedure, Breast Reconstruction Autologous with Implant Rio de Janeiro Local News, Breast Reconstruction Autologous with Implant Rio de Janeiro Surgeon Locator and other Breast Reconstruction Autologous with Implant related material.
Breast Reconstruction Autologous with Implant Procedure
Breast reconstruction is a surgical procedure usually designed to reconstruct the breast of patients who have had a mastectomy due to breast cancer. Depending upon the patient, there may be several different options for breast reconstruction involving breast implants as well as using the patient's own tissues. Not every patient will be a candidate for every reconstructive technique.
Autologous tissue is tissue taken from another part of your body. This animation shows a breast reconstruction that is performed at a later date than the mastectomy. Sometimes a breast reconstruction may take place during the mastectomy.
An incision is made along the previous scar and dissection is carried down through the tissues to the chest wall.
Tissue from the abdomen or the back is dissected from its normal location and rotated into the mastectomy site to re-create the new breast. Important blood vessels are left attached and intact to provide blood to the tissue.
An implant is placed underneath the autologous tissue to increase the size of the reconstructed breast.
The nipple and areola are reconstructed with either local tissue and tattooing or a skin graft from your inner thigh.
Autologous reconstruction with an implant may be a good option in certain candidates; however, this can only be determined after consultation with your surgeon. Depending on the reconstructive technique utilized, the healing time can be from four to eight weeks or longer. If the abdominal tissue is utilized, the healing process will be longer. If the muscle from the back is used, the healing time is usually shorter. Breast reconstruction is a complex procedure and results vary.
The patient is placed in a compression garment or bra. Compression garments are an important part of the recovery process. The garment provides support, comfort and helps to minimize swelling. The patient is usually wearing a bra or some type of supportive garment at all times, except when showering. Healing time is approximately three months. Scarring is variable and often depends on the patient's ability to heal.
Other Breast Reconstruction Autologous with Implant Procedures
All Breast Procedures
Breast Reconstruction Autologous with Implant rio-de-janeiro (current)
rio-de-janeiro Breast Lift
rio-de-janeiro Breast Implants
rio-de-janeiro Implant Removal
rio-de-janeiro Armpit Incision
More Rio de Janeiro info...
Rio de Janeiro By taxi
A cab is one of the best ways to move around Rio. All legal cabs are yellow with a blue stripe painted on the sides. Taxis not designed like this are special service cars (to the airport or bus stations) or illegal. Rio has some of the cheapest taxi systems in the world, so don't bother spending a little more in exchange of speed and safety. Most of the tours in the South Zone will cost around R$15, and the car can usually hold four people. You can ask a cab for a city tour, and arrange a fixed price (may be around US$20). Major taxi companies include Central de Taxi, Ouro Taxi and Yellow Taxi.
After getting into the taxi, check to see if the taximeter has been started (as of December 2006, it charges R$ 4.30 for the minimum ride, called bandeirada). If not, ask the taxi driver to do so. You may be ripped off by some taxi drivers. Avoid the blue, green, and white taxis as they tend to charge considerably more for the same ride.
-
Plastic Surgery News...
- A report on 5 years treatment with infliximab in patients with ankylosing spondylitis (AS) has been published in the Annals of the Rheumatic Diseases. These patients had initially been treated with infliximab in a 12-week, double-blind, placebo-controlled study (n=69) and at week 12, patients initially assigned to placebo switched to infliximab. Clinical efficacy was maintained in several open-label extension phases of this study in which patients were treated continuously with infliximab infusions of 5 mg/kg every 6 weeks for up to 3 years (FU1). After a short phase of discontinuation and restart of infliximab therapy because of clinical relapse, patients received continuous treatment. The primary outcome of this extension was remission according to the ASsessment in Ankylosing Spondylitis (ASAS) criteria at the end of year 5 of the study (FU2). Of the 43 patients who completed year 3, 42 agreed to continue, 38 of which (90.5%) finished year 5 (55% of 69 initially). The following findings were reported:
• Partial clinical remission was achieved in 13 of 38 patients (34.2%) at FU1 and FU2.
• At FU2, the mean Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was 2.5 (baseline: 6.4, FU1:2.5).
• BASDAI values < 4 were seen in 79% of patients at both, FU1 and FU2.
• ASAS 20% and 40% responses were seen in 32 (84%) and 24 (63%) patients at FU2, respectively.
• During the fourth and fifth year of the study, 36 of 38 patients (94.7%) reported at least one adverse event; the most frequently reported events were common cold (41%), bronchitis (11%) and increase of liver enzymes (6.5%).
• Six of the 43 patients (14%) at FU1 reported serious adverse events (SAE) during years 4 and 5 of the study: 1 patient withdrew because of recurrent vaginal infections and the other patient due to repeated infections of the upper respiratory tract.
The researchers conclude “this study shows that therapy of AS patients is efficacious and safe over 5 years of almost continuous treatment. There was no indication of loss of response as indicated by the persistent rate of remission and low disease activity. As we had tried to discontinue therapy after 3 years without success we believe that continuous therapy is necessary to achieve a lasting effect in these patients.”
- The Christian Science Monitor on Wednesday examined how "soaring inflation and shrinking tax revenues have combined to place state budgets" across the U.S. "under severe stress." At least 25 states will face deficits in fiscal year 2009 with a combined budget deficit totaling at least $39 billion, according to data compiled by the Center on Budget and Policy Priorities.